Our recent survey of more than 100 global Contract Research Organizations (CROs) uncovered a number of revelations – some surprising, and some reflecting further validation of a market that is growing but with its challenges.
Over the past number of years, outsourcing various aspects of clinical trials has become a steady and ongoing practice for pharmaceutical organizations. In most cases, outsourcing activities such as site management, subject recruitment and data management has provided relief for pharmaceuticals whose time and efforts can be focused on treatments, drug design and delivery. However, the trade-off results in some serious considerations for both Sponsor and CRO in terms of study project management, cost and compliance.